Showing results (21-30 of 33) with videos related to
Sort By:
Pageof 4
Hypertension Research : Official Journal of the Japanese Society of Hypertension|June 6, 2002
Inhibition of migration and proliferation of rat vascular smooth muscle cells by a new HMG-CoA reductase inhibitor, pitavastatinMasakazu Kohno, Kaori Shinomiya, Satomi Abe, et al.Frontiers in Veterinary Science|July 1, 2021
Canine Transforming Growth Factor-β Receptor 2-Ig: A Potential Candidate Biologic for Melanoma Treatment That Reverses Transforming Growth Factor-β1 ImmunosuppressionHiroto Takeuchi, Satoru Konnai, Naoya Maekawa, et al.Scientific Reports|November 8, 2018
VGF nerve growth factor inducible is involved in retinal ganglion cells death induced by optic nerve crushHiroto Takeuchi, Satoshi Inagaki, Wataru Morozumi, et al.The Journal of Nutritional Biochemistry|February 5, 2022
Eicosapentaenoic acid suppresses cisplatin-induced muscle atrophy by attenuating the up-regulated gene expression of ubiquitinYohei Ikeno, Maya Inomata, Yuka Tsukimura, et al.Molecular Pain|June 2, 2021
Increased nerve growth factor expression in the synovial tissues of patients with rotator cuff tearsRyo Tazawa, Tomonori Kenmoku, Kentaro Uchida, et al.Journal of Virological Methods|June 26, 2025
Development of a novel plate reader-based antibody-dependent enhancement (ADE) assay for orthoflavivirus infectionsYannis Aklil, Hiroto Takeuchi, Gabriel Gonzalez, et al.Scientific Reports|June 6, 2022
Exploration of serum biomarkers in dogs with malignant melanoma receiving anti-PD-L1 therapy and potential of COX-2 inhibition for combination therapyNaoya Maekawa, Satoru Konnai, Yumie Asano, et al.Cancers|June 10, 2023
Enhanced Systemic Antitumour Immunity by Hypofractionated Radiotherapy and Anti-PD-L1 Therapy in Dogs with Pulmonary Metastatic Oral Malignant MelanomaTatsuya Deguchi, Naoya Maekawa, Satoru Konnai, et al.Plos One|January 26, 2023
Molecular characterization of feline immune checkpoint molecules and establishment of PD-L1 immunohistochemistry for feline tumorsNaoya Maekawa, Satoru Konnai, Yumie Asano, et al.Plos One|October 4, 2023
Safety and clinical efficacy of an anti-PD-L1 antibody (c4G12) in dogs with advanced malignant tumoursNaoya Maekawa, Satoru Konnai, Kenji Hosoya, et al.Pageof 4